New drug aims to fix Chemo's side effect: low platelets
NCT ID NCT06456528
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a drug called QL0911 for people whose platelet levels drop too low due to cancer treatment. Low platelets can delay chemotherapy and cause bleeding risks. The trial will compare QL0911 to a placebo in 235 adults aged 18-75 to see if it safely raises platelet counts and helps patients complete their chemo on schedule.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CANCER TREATMENT-INDUCED THROMBOCYTOPENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Harbin First Hospital
RECRUITINGHarbin, China
-
Nanjing Tianyinshan Hospital
RECRUITINGNanjing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.